Company Filing History:
Years Active: 2013-2023
Title: Innovations by Madhavi Gangapuram in Cancer Treatment
Introduction
Madhavi Gangapuram is a notable inventor based in Tallahassee, Florida. She has made significant contributions to the field of cancer research, particularly in developing novel treatments for triple-negative breast cancer. With a total of five patents to her name, her work is paving the way for new therapeutic approaches.
Latest Patents
One of her latest patents focuses on substituted tetrahydroisoquinolines as anti-mitotic drugs in triple-negative breast cancer. This patent presents novel compositions and methods for using these compositions to treat the disease. The compound 4-Ethyl-N-(7-hydroxy-3,4-dihydroisoquinolin-2(1H)-yl) benzamide has demonstrated the ability to downregulate the expression of several genes associated with triple-negative breast cancer, including amphiregulin, epiregulin, inhibitor of DNA binding 1, inhibitor of DNA binding 3, killer cell lectin-like receptor C3, cyclooxygenase-2, and intercellular adhesion molecule 1. Additionally, it has been shown to downregulate the oncostatin M signaling pathway. Another significant patent involves the use of N-(4-iodobenzoylamino)-5-ethyl-1,2,3,6-tetrahydropyridine as a treatment for cancer, showcasing her innovative approach to tackling this challenging disease.
Career Highlights
Madhavi Gangapuram is affiliated with Florida A&M University, where she continues her research and development efforts. Her work is characterized by a commitment to advancing cancer treatment options and improving patient outcomes.
Collaborations
Madhavi has collaborated with esteemed colleagues such as Kinfe Ken Redda and Karam F A Soliman, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Madhavi Gangapuram's contributions to cancer research through her patents and collaborations highlight her dedication to finding effective treatments for challenging diseases. Her innovative work continues to inspire advancements in the field of oncology.